INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Corporate insider
DC

Davis Todd C

Director, Chief Executive OfficerCIK 0001392029

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells2 / 0
Max Insider Score47
Connections2with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
18
DC
Davis Todd CDirector, Chief Executive Officer
LGNDLIGAND PHARMACEUTICALS INC
Other acquisition or disposition
J$21K
132 sh
Jun 30, 2026Jul 6, 2026
traded Jun 30, 2026
+6dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Pelthos Therapeutics Inc.Director · Jun 15, 2026
  • Insider ofevidence
    LIGAND PHARMACEUTICALS INCDirector, Chief Executive Officer · Dec 8, 2025
47
DC
Davis Todd CDirector
PTHSPelthos Therapeutics Inc.
Open-market purchase
BUY
$986K
35.4K sh
Jun 11, 2026
Jun 15, 2026
traded Jun 11, 2026
+4d
SEC FORM 4

Evidence

29
DC
Davis Todd CDirector
PTHSPelthos Therapeutics Inc.
Open-market purchase
BUY$14K
503 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC FORM 4

Evidence

23
DC
Davis Todd CDirector, Chief Executive Officer
LGNDLIGAND PHARMACEUTICALS INC
Grant or award
A—
10.5K sh
Mar 2, 2026Mar 27, 2026
traded Mar 2, 2026
+25dSEC FORM 4

Evidence

19
DC
Davis Todd CDirector, Chief Executive Officer
LGNDLIGAND PHARMACEUTICALS INC
Grant or award
A—
50.1K sh
Mar 2, 2026Mar 27, 2026
traded Mar 2, 2026
+25dSEC FORM 4

Evidence

12
DC
Davis Todd CDirector, Chief Executive Officer
LGNDLIGAND PHARMACEUTICALS INC
Gift
G—
130 sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC FORM 4

Evidence